CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Open-market sale Director sold 9,000 shares at $19.06 ($171,540)
- 4 Open-market sale Director sold 7,500 shares at $19.13 ($143,475)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Open-market sale Director sold 12,000 shares at $19.21 ($230,520)
- 4 Open-market sale President & CEO sold 87,500 shares at $17.83 ($1,560,125)
- 4 Open-market sale SVP & Chief Operating Officer sold 3,317 shares at $17.56 ($58,247)
- 4 Open-market sale SVP & Chief Accounting Officer sold 3,971 shares at $17.56 ($69,731)
- 4 Open-market sale President & CEO sold 11,817 shares at $17.56 ($207,507)
- 4 Open-market sale SVP & Chief Financial Officer sold 3,305 shares at $17.56 ($58,036)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 3,305 shares at $17.56 ($58,036)
- 4 Open-market sale SVP & Chief Medical Officer sold 1,685 shares at $17.56 ($29,589)
Page 24 of 49 · 970 filings